Structural and functional characterization of the NHR2 and Runt domains of AML1/ETO.

被引：0
|
作者：
Cheney, MD
Liu, YZ
Zhou, YP
Chruszcz, M
Laue, TM
Minor, W
Bushweller, JH
Speck, NA
机构：
[1] Dartmouth Coll Sch Med, Dept Biochem, Hanover, NH USA
[2] Univ Virginia, Dept Mol Physiol & Biophys, Charlottesville, VA 22903 USA
[3] Univ New Hampshire, Dept Biochem, Durham, NH 03824 USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
482
引用
收藏
页码：141A / 141A
页数：1
相关论文
共 50 条
  • [21] FUNCTIONAL DOMAINS OF THE T(8-21) FUSION PROTEIN, AML-1/ETO
    LENNY, N
    MEYERS, S
    HIEBERT, SW
    ONCOGENE, 1995, 11 (09) : 1761 - 1769
  • [22] The AML1/ETO(MTG8) and AML1/Evi-1 leukemia-associated chimeric oncoproteins accumulate PEBP2β(CBFβ) in the nucleus more efficiently than wild-type AML1
    Tanaka, K
    Tanaka, T
    Kurokawa, M
    Imai, Y
    Ogawa, S
    Mitani, K
    Yazaki, Y
    Hirai, H
    BLOOD, 1998, 91 (05) : 1688 - 1699
  • [23] Multiple functional domains of AML1: PU.1 and C/EBP alpha cooperate with different regions of AML1.
    Petrovick, MS
    Hiebert, SW
    Friedman, AD
    Hetherington, CJ
    Tenen, DG
    Zhang, DE
    BLOOD, 1997, 90 (10) : 174 - 174
  • [24] PML-RARα and AML1–ETO translocations are rarely associated with methylation of the RARβ2 promoter
    Yoko Tabe
    Marina Konopleva
    Yutaka Kondo
    Rooha Contractor
    Linhua Jin
    Vivian Ruvolo
    Yuko Tsutsumi-Ishii
    Kazunori Miyake
    Noriko Miyake
    Akimichi Ohsaka
    Isao Nagaoka
    Jean-Pierre J. Issa
    Michael Andreeff
    Annals of Hematology, 2006, 85 : 689 - 704
  • [25] Epigenetic repression of the adaptor molecule LAT2 by the leukemic fusion protein AML1/ETO
    Duque-Afonso, Jesus
    Berg, Tobias
    Heidenreich, Olaf
    Luebbert, Michael
    BLOOD, 2007, 110 (11) : 300A - 300A
  • [26] IDENTIFICATION OF BREAKPOINTS IN T(8-21) ACUTE MYELOGENOUS LEUKEMIA AND ISOLATION OF A FUSION TRANSCRIPT, AML1/ETO, WITH SIMILARITY TO DROSOPHILA SEGMENTATION GENE, RUNT
    ERICKSON, P
    GAO, J
    CHANG, KS
    LOOK, T
    WHISENANT, E
    RAIMONDI, S
    LASHER, R
    TRUJILLO, J
    ROWLEY, J
    DRABKIN, H
    BLOOD, 1992, 80 (07) : 1825 - 1831
  • [27] Aml1/ETO and Pml/RARA rearrangements in a case of AML-M2 acute myeloblastic leukemia with t(15;17)
    Varella-Garcia, M
    Brizard, F
    Roche, J
    Flandrin, G
    Drabkin, H
    Brizard, A
    LEUKEMIA & LYMPHOMA, 1999, 33 (3-4) : 403 - 406
  • [28] AML1, AML2, AND AML3, THE HUMAN MEMBERS OF THE RUNT DOMAIN GENE-FAMILY - CDNA STRUCTURE, EXPRESSION, AND CHROMOSOMAL LOCALIZATION
    LEVANON, D
    NEGREANU, V
    BERNSTEIN, Y
    BARAM, I
    AVIVI, L
    GRONER, Y
    GENOMICS, 1994, 23 (02) : 425 - 432
  • [29] The AML1/ETO target gene LAT2 interferes with differentiation of normal hematopoietic precursor cells
    Essig, Aitomi
    Duque-Afonso, Jesus
    Schwemmers, Sven
    Pahl, Heike L.
    Luebbert, Michael
    LEUKEMIA RESEARCH, 2014, 38 (03) : 340 - 345
  • [30] Structural basis for recognition of SMRT/N-CoR by the MYND domain and its contribution to AML1/ETO's activity
    Liu, Yizhou
    Chen, Wei
    Gaudet, Justin
    Cheney, Matthew D.
    Roudaia, Liya
    Cierpicki, Tomasz
    Klet, Rachel C.
    Hartman, Kari
    Laue, Thomas M.
    Speck, Nancy A.
    Bushweller, John H.
    CANCER CELL, 2007, 11 (06) : 483 - 497
12345